Escuela de doctorado
BIOCIENCIAS: Bª Y CLÍNICA DEL CÁNCER Y MEDIC. TRASLACIONAL
Publicacións (16) Publicacións nas que participase algún/ha investigador/a
2016
-
Acral peeling skin syndrome resulting from mutations in TGM5
Journal of the European Academy of Dermatology and Venereology
-
Asistencia ventricular con oxigenador extracorpóreo de membrana: un arma de doble filo. Respuesta
Revista Espanola de Cardiologia
-
Comment on 'Wild-type APC prediction of poor prognosis in microsatellite-stable proximal colorectal cancer differs according to the age of onset'
British Journal of Cancer
-
Competencias profesionales y trabajo en equipo en pacientes con enfermedades cardiacas agudas y críticas. Respuesta
Revista Espanola de Cardiologia
-
Complete response to gemtuzumab ozogamicin in a patient with refractory mast cell leukemia
Leukemia
-
Consenso español sobre los riesgos y detección de la hiperprolactinemia iatrogénica por antipsicóticos
Revista de Psiquiatria y Salud Mental
-
Data from acellular human heart matrix
Data in Brief
-
Downregulation of Protection of Telomeres 1 expression in myelodysplastic syndromes with 7q deletion
British Journal of Haematology
-
Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356
Autophagy
-
European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma
Haematologica
-
GvHD prophylaxis with tacrolimus plus sirolimus after reduced intensity conditioning allogeneic transplantation: Results of a multicenter study
Bone Marrow Transplantation
-
Mesalazine-induced eosinophilic pneumonia in a patient with ulcerative colitis disease: a case report and literature review
International Journal of Colorectal Disease
-
Molecular control of non-muscle myosin II assembly
Oncotarget
-
Nutrients control cell size
Cell Cycle
-
Proximity of AUG sequences to initiation codon in genomic 5′ UTR regulates mammalian protein expression
Gene
-
The addition of ofatumumab to the conditioning regimen does not improve the outcome of patients with high-risk CLL undergoing reduced intensity allogeneic haematopoietic cell transplantation: A pilot trial from the GETH and GELLC (CLL4 trial)
Bone Marrow Transplantation